611P ESMO-magnitude of clinical benefit scale (MCBS) scores for phase III trials of adjuvant and curative therapies at the 2022 ASCO annual meeting (ASCO22).
In: Annals of Oncology, Jg. 34 (2023-11-03), S. S1711
academicJournal
Zugriff:
Titel: |
611P ESMO-magnitude of clinical benefit scale (MCBS) scores for phase III trials of adjuvant and curative therapies at the 2022 ASCO annual meeting (ASCO22).
|
---|---|
Autor/in / Beteiligte Person: | Mando, P. ; Faisal, M.S. ; Jatwani, K. ; Seghers, S. ; Young, J. ; Teuwen, L-A.M.N. ; Prenen, H. ; Luong, T.T.V. ; Segelov, E. |
Link: | |
Zeitschrift: | Annals of Oncology, Jg. 34 (2023-11-03), S. S1711 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 0923-7534 (print) |
DOI: | 10.1016/j.annonc.2023.10.326 |
Schlagwort: |
|
Sonstiges: |
|